Class Action Lawsuit Filed Against Warner Chilcott Ltd.
A class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased the publicly traded common stock of Warner Chilcott Limited pursuant and/or traceable to the Company’s Registration Statement and Prospectus issued in connection with the initial public offering of Warner Chilcott shares between September 20, 2006 and September 26, 2006, alleges that the defendants violated Sections 11, 12(a) and 15 of the Securities Act of 1933.
The Company’s Registration Statement and Prospectus issued in connection with the IPO failed to disclose that shortly prior to the IPO, the Company had stopped shipping Ovcon 35, Warner Chilcott’s top selling birth control pill and a primary source of revenue for the Company.
If you purchased or otherwise acquired the publicly traded common stock of Warner Chilcott pursuant and/or traceable to the Company’s Registration Statement and Prospectus issued in connection with the IPO, you may, no later than January 7, 2007, request that the Court appoint you as lead plaintiff.
Filed under Class Action, General Law
You may also like to read
- Warner Chilcott Ltd. in Securities Class Action Lawsuit
- Class Action Lawsuit Filed Against Warner Chilcott Limited
- Class Action Lawsuit Filed Against Warner Chilcott Limited
- $2.65 Billion AOL Class-Action Settlement Approved
- America Online Inc. Agreed to Settle A Class Action Lawsuit for $25 Million
- Settlement agreement addes major boost to diabetes research
- Important Libel Cases in USA
